Eudaimonia Partners’s Avanos Medical AVNS Stock Holding History

Eudaimonia Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-188	Closed	-$8K	–	449
2021 Q1	$8K	Buy	+188	New	+$8.82K	﹤0.01%	1211

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Eudaimonia Partners's AVNS Position: Q2 2021 in Review

Eudaimonia Partners sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 188 shares — an estimated $8K sold.

Eudaimonia Partners first reported a position in AVNS in Q1 2021 and held it in 1 quarter. The position peaked at $8K in Q1 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

Eudaimonia Partners reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 188 Avanos Medical shares in Q2 2021, an estimated $8K.
Eudaimonia Partners first reported a position in Avanos Medical in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Avanos Medical position peaked at $8K in Q1 2021.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.